Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             246 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aberrant hippocampal intrinsic morphological connectivity patterns in Neuromyelitis optica spectrum disorder with cognitive impairment: Insights from an individual-based morphological brain network Wang, Xin

92 C p.
artikel
2 97. Acute Extensive Longitudinal Myelitis: Challenges in Differential Diagnosis between Spinal Cord Ischemia and Inflammatory Disease Imen, Ben Kraiem

92 C p.
artikel
3 8. Agreement of Large Language Models with Humans in Extracting Data from Unstructured Records of Multiple Sclerosis Patients Alnhwi, Zainab Ali

92 C p.
artikel
4 AI-assisted assessment of fall risk in multiple sclerosis: A systematic literature review Mehrlatifan, Somayeh

92 C p.
artikel
5 136. AMALXR: A Home-Based Virtual Self-Rehabilitation Tool for Patients with Multiple Sclerosis Belghith, Mohamed

92 C p.
artikel
6 14. An Algorithm for Assessment and Correction of Walking in Patients with Multiple Sclerosis Lysogorskaia, Elena

92 C p.
artikel
7 139. An Update of Systematic Review and Meta-analysis: The Effect of Cigarette Smoking on the Progression of Multiple Sclerosis Ali, Ahmed Essmat

92 C p.
artikel
8 Appointment non-attendance is associated with disease modifying therapy persistence the following year Gromisch, Elizabeth S.

92 C p.
artikel
9 A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis Davenport, Laura

92 C p.
artikel
10 109. A Real-world Data of Serum Neurofilament Light Chain in a Large Cohort of Egyptian Multiple Sclerosis Patients: A Hospital-based Study Khedr, Eman Mohamed

92 C p.
artikel
11 Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data Ata, Nasar

92 C p.
artikel
12 Assessing and tailoring predictive equations of VO2max for women with multiple sclerosis with mild to moderate disability Morrone, Marco

92 C p.
artikel
13 93. Assessing the Correlation Between COVID-19 and Immunization Vaccine in Multiple Sclerosis Patients in Riyadh's MNGHA Alanazi, Asma

92 C p.
artikel
14 Assessing the landscape and charting paths: UK neurology trainees’ opinions on neuroinflammation subspecialty Arun, Tarunya

92 C p.
artikel
15 122. Assessment of Cognitive Function in Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD) Compared to Patients with Multiple Sclerosis Kasatkin, Dmitry

92 C p.
artikel
16 131. Assessment of Cognitive Functions, Gait Affaction and Fatigue in Relapsing- remitting Multiple Sclerosis Patients Abdeldayem, Mai Mohamed

92 C p.
artikel
17 106. Assessment of Depression and Anxiety in Patients with Multiple Sclerosis in Morocco Hind, Bel Amgharia

92 C p.
artikel
18 40. Assessment of Serum Zonulin as a Marker of Altered Intestinal Permeability in Patients with Multiple Sclerosis Nassief, Ayman M

92 C p.
artikel
19 142. Assessment of the Quality of Life of Patients with Multiple Sclerosis in Morocco Lotfi, Rachid

92 C p.
artikel
20 85. Association Between Corpus Callosum Damage and Clinical Disability in Multiple Sclerosis Farhat, Nouha

92 C p.
artikel
21 60. Atypical Presentation of Anti-MOG antibody-associated Disease: Aseptic Meningitis and Arachnoiditis Imen, Ben Kraiem

92 C p.
artikel
22 117. Atypical Presentation of NMOSD Revealed by Trigeminal Neuralgia Bouattor, Nadia

92 C p.
artikel
23 98. Balò concentric sclerosis or glioma? A case of a challenging diagnosis Farhat, Nouha

92 C p.
artikel
24 178. B-cell Levels and Placental Transfer in Infants Potentially Exposed to Ocrelizumab During Pregnancy: Primary Analysis of the Prospective Multicentre, Open-label Phase IV MINORE study Hellwig, K.

92 C p.
artikel
25 175. B-cell Levels in Infants of Lactating Women with Multiple Sclerosis Receiving Ocrelizumab: SOPRANINO Primary Results Hellwig, K

92 C p.
artikel
26 Blood neutrophils, oligoclonal bands and bridging corticosteroids as predictive factors for MOGAD course: Insights from a multicentric Portuguese cohort Neves, Ana Lídia

92 C p.
artikel
27 44. Breaking Free from the Six-Month Cycle Al-Draye, Hamad

92 C p.
artikel
28 171. Cardiac Abnormalities Associated with Fingolimod Initiation in a Real-Life Cohort Aljarallah, Salman

92 C p.
artikel
29 29. Central Vein Sign Assessment in Multiple Sclerosis: A Multi-Parametric Approach Hannoun, Salem

92 C p.
artikel
30 35. Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels at Baseline Predict Disease Activity and Severity in Neuromyelitis Optica Spectrum Disorder Patients Mrabet, Saloua

92 C p.
artikel
31 159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes Oh, Jiwon

92 C p.
artikel
32 Clinical characteristics of pediatric and adult myelin oligodendrocyte antibody-associated disease (MOGAD): A single-center study in the Northeast Brown, Allison M

92 C p.
artikel
33 46. Clinical overlap of multiple sclerosis and autoimmune hepatitis: A coincidental association? A case report and review of the literature Paybast, Sepideh

92 C p.
artikel
34 6. Clinical Overlap of Multiple Sclerosis and Primary Biliary Cirrhosis: A Coincidental Association - A Case Report and Review of the Literature Paybast, Sepideh

92 C p.
artikel
35 9. Clinical Profile of Seizures in Multiple Sclerosis Patients in a Tertiary Care Center Alrushid, Eythar

92 C p.
artikel
36 105. Clinical Relevance of Circular RNA circ_0005402 Expression in Multiple Sclerosis in a Cohort of Egyptian Patients Nasr, Nada Mohamed Nasr

92 C p.
artikel
37 Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience Saridas, Furkan

92 C p.
artikel
38 56. Coffee and Caffeine as a Cognitive Enhancer in Multiple Sclerosis: A Systematic Review Salekzamani, Shabnam

92 C p.
artikel
39 57. Cognitive Decline and Motor Handicap in Multiple Sclerosis Patients Farhat, Nouha

92 C p.
artikel
40 169. Combining Metformin and Clemastine for Enhanced Remyelination in Multiple Sclerosis Alskaf, Asma Samir

92 C p.
artikel
41 130. Community Mobility in Patients with Multiple Sclerosis in Saudi Arabia – A Qualitative Study Analysis Basharahil, Saja Omar

92 C p.
artikel
42 Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review Frank, Hanna A.

92 C p.
artikel
43 47. Comparison of Fingolimod vs. Dimethyl Fumarate as Naïve Treatment in Patients with Relapse-remitting Multiple Sclerosis: A Five-year Follow-up Study Paybast, Sepideh

92 C p.
artikel
44 61. Co-occurrence of Anti-MuSK Myasthenia Gravis and Multiple Sclerosis: A Case Report and Literature Review Bakharji, Ahmed

92 C p.
artikel
45 112. Correlation of Magnetic Resonance Imaging with cognitive impairment in Multiple Sclerosis Farhat, Nouha

92 C p.
artikel
46 148. Correlations Between Cognitive Impairment and Multiple Sclerosis Treatments Farhat, Nouha

92 C p.
artikel
47 Corrigendum to “Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment” [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949] Sen, Sedat

92 C p.
artikel
48 135. Cost Effectiveness of Rapid Infusion Time of Ocrelizumab and Can Safely Be Delivered in Saudi Tertiary Hospital Alhartani, Mohammed Muneer

92 C p.
artikel
49 De-escalation from anti-CD20 to cladribine tablets in multiple sclerosis: A pilot study Sacco, Rosaria

92 C p.
artikel
50 18. Demographics and Clinical Assessment of Familial Multiple Sclerosis Patients in Ain Shams University Hospitals Abdulnaser, Azza

92 C p.
artikel
51 Development and psychometric evaluation of the treatment management adherence scale for children with multiple sclerosis Yüksel, Didem

92 C p.
artikel
52 Development of a new patient-reported outcome measure for patients with multiple sclerosis: the Multiple Sclerosis Autonomy Scale (MSAS) Donzé, Cécile

92 C p.
artikel
53 Development, validity and reliability of the “Multiple sclerosis stigma scale” Sariahmetoglu, Hande

92 C p.
artikel
54 62. Diagnostic and Therapeutic Challenges in Seronegative Forms of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: A Case Report Imen, Ben Kraiem

92 C p.
artikel
55 16. Diagnostic Utility of the Central Vein Sign in Multiple Sclerosis with Implementation of the 6 Lesion Rule Alsalamah, Seham

92 C p.
artikel
56 107. Differential Gene Expression in Bahraini Patients with Multiple Sclerosis Alnashmi, Moudhi Essa

92 C p.
artikel
57 141. Digital Impact on the Management of Multiple Sclerosis Costa, Jad

92 C p.
artikel
58 25. Disconnection and Atrophy in Brain Regions of MS Converters: Insights into Disease Progression Hannoun, Salem

92 C p.
artikel
59 155. Disease-Modifying Drugs Effect on Plasmacytoid Dendritic Cells in Multiple Sclerosis Patients Rageh, Tarek

92 C p.
artikel
60 38. Diverse Clinical Patterns and Outcomes in MOG Related Disorders in Adults: Insights from a Multi-center Study in Pakistan Imtiaz, Hina

92 C p.
artikel
61 32. Does Quantitative MRI Parameters Help To Solve The Clinic-Radiological Paradox in Multiple Sclerosis? El-Tallawy, Hamdy N

92 C p.
artikel
62 67. Domain-Specific and Global Cognitive Impairment in Multiple Sclerosis Patients Based on Cambridge Neuropsychological Test Automated Battery Sahebari, Sepideh Seyedi

92 C p.
artikel
63 69. Do People with Multiple Sclerosis in Saudi Arabia Want to Know their Prognosis? A Cross-sectional Nationwide Study Malik, Yaser M. Al

92 C p.
artikel
64 127. Early Progression to Secondary Progressive Multiple Sclerosis in South Tunisia Bouaziz, Fatma

92 C p.
artikel
65 Early rituximab versus escalating therapy in neuromyelitis optica: A cost and quality of life analysis Silva, Guilherme Diogo

92 C p.
artikel
66 50. Effectiveness of 6-week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis: An Observational Registry-Based Study Alroughani, Raed

92 C p.
artikel
67 Effects of multiple treatments with stem cell therapy in patients with multiple sclerosis Fan, Liding

92 C p.
artikel
68 11. Effects of Trunk Rehabilitation on Balance, Gait, Fall and Community Mobility in Patients with Multiple Sclerosis: A Randomised Clinical Trial Mukhtar, Shatha Mohammed

92 C p.
artikel
69 167. Efficacy and Safety of Natalizumab: Follow up and Real-life Results of an Algerian Hospital Series Kediha, Mohamed Islam

92 C p.
artikel
70 153. Efficacy and Safety of Tolebrutinib Versus Placebo in Non-Relapsing Secondary Progressive Multiple Sclerosis: Results From the Phase 3 HERCULES Trial Fox, Robert J.

92 C p.
artikel
71 154. Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results From the Phase 3 GEMINI 1 and 2 Trials Oh, Jiwon

92 C p.
artikel
72 152. Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial Vermersch, Patrick

92 C p.
artikel
73 144. Efficacy of Ocrelizumab in Multiple Sclerosis Patients in Saudi Arabia: A Registry-Based Study Althobaiti, Ahmed

92 C p.
artikel
74 173. Efficacy of Pulsed Electromagnetic Field Therapy on Fatigue for Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis Mansour, Mohamed Ezzat Mahmoud

92 C p.
artikel
75 24. Enhancing Cognitive Function and Neuroplasticity Assessed by Diffusion Tensor imagin in Multiple Sclerosis: The Efficacy of Combined Transcranial Direct Current Stimulation and Application-Assisted Cognitive Rehabilitation Roozbeh, Mehrdad

92 C p.
artikel
76 Epstein-Barr nuclear antigen 1 antibody-based indices are increased in patients with multiple sclerosis Ali, Rimsha

92 C p.
artikel
77 Establishing consensus on lifestyle recommendations and behaviour change strategies to promote brain health-focussed care for multiple sclerosis: A modified e-Delphi study Wills, Olivia

92 C p.
artikel
78 54. Ethical Dilemmas Revolving Around Use of Medical Cannabis for MS in Pakistan Ashfaq, Ayesha

92 C p.
artikel
79 Etiology and characteristics of pseudotumoral lesions and tumefactive demyelination in multiple sclerosis Tamas, Olivera

92 C p.
artikel
80 180. Evaluation of the Cost-effectiveness of Ofatumumab for Relapsing Multiple Sclerosis in the United Arab Emirates Inshasi, Jihad

92 C p.
artikel
81 34. Evaluation of the Predictive Value of the Bands CSF Oligoclonals on the Prognosis in Terms of Disability and Risk of rRelapse in Patients Adults with MOGAD Baitha, Khadija

92 C p.
artikel
82 43. Experience with Autologous Stem Cell Transplant in Multiple Sclerosis in the UAE Mir, Ruqqia

92 C p.
artikel
83 13. Explaining the Clinical and MRI Dissociation in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Ali, Eman Nassim

92 C p.
artikel
84 73. Exploring Risk Factors for the Severity of Bowel Dysfunction, Urinary Dysfunction, and Fatigue in Multiple Sclerosis Ketata, Imen

92 C p.
artikel
85 Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study Seferoğlu, Meral

92 C p.
artikel
86 138. Factors Affecting the Quality of Sleep and Physical Activity Participation of Multiple Sclerosis (MS) Patients: A Path Analysis Khalil, Hanan

92 C p.
artikel
87 126. Familial Pediatric Onset Multiple Sclerosis: A Retrospective Single-Center Observational Study Majoul, Mohamed Slim

92 C p.
artikel
88 177. Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension Bar-Or, Amit

92 C p.
artikel
89 Frailty in multiple sclerosis: A scoping review Al Worikat, Nida’

92 C p.
artikel
90 66. Frequency and Predictors of Cognitive Impairment Among Drug–Naïve Multiple Sclerosis Patients: Hospital-based study Khedr, Eman M

92 C p.
artikel
91 Frequency of anti-MOG antibodies in serum and CSF of patients with possible autoimmune encephalitis: Results from a Brazilian multicentric study de Freitas Dias, Bruna

92 C p.
artikel
92 150. Frexalimab in Relapsing Multiple Sclerosis and Non-Relapsing Secondary Progressive Multiple Sclerosis: Design of Phase 3 Frexalt and Freviva Trials Krieger, Stephen

92 C p.
artikel
93 110. Frexalimab Reduces Plasma Neurofilament Light Chain in Relapsing Multiple Sclerosis: Week 48 Data from a Phase 2 Trial Kuhle, J.

92 C p.
artikel
94 81. Gender Difference In Egyptian Patients With Multiple Sclerosis Hammad, Mohamed Ahmed

92 C p.
artikel
95 88. Gender Issues in Multiple Sclerosis Kacem, Amal Hadj

92 C p.
artikel
96 137. Gender-related Quality of Life in People with Multiple Sclerosis Souissi, Amira

92 C p.
artikel
97 91. Headache and Multiple Sclerosis: Is It Disease Related or Treatment Related? Younis, Hossam Hamdy Abdelhady

92 C p.
artikel
98 History of head trauma and the risk of multiple sclerosis: A systematic review and meta-analysis Abouelmagd, Moaz Elsayed

92 C p.
artikel
99 9-HODE associates with thalamic atrophy and predicts white matter damage in multiple sclerosis Fung, Wing Hee

92 C p.
artikel
100 82. Idiopathic Intracranial Hypertension as A Presenting Symptom of Multiple Sclerosis: A Case Report Meshref, Mostafa

92 C p.
artikel
101 134. Impact of Bowel Dysfunction, Urinary Dysfunction, and Fatigue on Quality of Life in Multiple Sclerosis Ketata, Imen

92 C p.
artikel
102 Impact of insurance status on MRI phenotypes in MS Martin, Melissa Lynne

92 C p.
artikel
103 1. Impact of Menopause on Quality of Life in Multiple Sclerosis Patients Oreja-Guevara, Celia

92 C p.
artikel
104 133. Impact of Multiple Sclerosis on Professional Activity Farah, Kchaou

92 C p.
artikel
105 132. Impact of Multiple Sclerosis on Social Participation: A Study of 41 Tunisian Patients Farah, Kchaou

92 C p.
artikel
106 74. Impact of Vascular Disease Risk Factors on Multiple Sclerosis Dridi, Fawez

92 C p.
artikel
107 55. Impact of Vitamin D Deficiency on Multiple Sclerosis Patients in Central Saudi Arabia Alsheikh, Sara

92 C p.
artikel
108 Implementing a multidisciplinary approach for older adults with multiple sclerosis: Geriatric neurology in practice Bahri, Mara

92 C p.
artikel
109 Improvement in depressive symptoms is associated with sustained improvement in fatigue impact in adults with multiple sclerosis Knowles, Lindsey M.

92 C p.
artikel
110 Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules Leodori, Giorgio

92 C p.
artikel
111 Improving manual dexterity using ergonomic wearable glove in patients with multiple sclerosis: A quasi-randomized clinical trial Ciatto, Laura

92 C p.
artikel
112 Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy compared to other disease modifying therapies Conway, Sarah

92 C p.
artikel
113 Interleukin-6 inhibitors for neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis Noll, Giovani

92 C p.
artikel
114 58. Intermediate Uveitis Revealing Multiple Sclerosis Hadjkacem, Donia

92 C p.
artikel
115 125. Investigating Psychoses in Pediatric-Onset Multiple Sclerosis: A Systematic Review of Case Reports Ketata, Imen

92 C p.
artikel
116 86. Investigating the Correlation between Pregnancy History, Oral Contraceptive Pill Use, and Cognitive Function in Patients with Multiple Sclerosis Rezaeimanesh, Nasim

92 C p.
artikel
117 48. Investigating Treatment Alternatives for Fingolimod in Patients with Multiple sclerosis Developed Refractory Fingolimod-related Genital Human Papilloma Virus Infection Paybast, Sepideh

92 C p.
artikel
118 Is sedentary behavior associated with body composition in multiple sclerosis? Jeng, Brenda

92 C p.
artikel
119 Is there a relationship between CSF Interleukin 34 Level and clinicoradiological activity and IgG index in patients with MS? Gökçe, Şeyda Figül

92 C p.
artikel
120 116. Late-onset Neuromyelitis Optica Spectrum Disorders: Clinical, Radiological Features and Prognostic Factors Othman, Oumayma Ben

92 C p.
artikel
121 5. Late-onset Neutropenia in a Cohort of Central Nervous System Autoimmunity Patients Treated with Anti-CD20 Althobaiti, Ahmed H.

92 C p.
artikel
122 149. Long-term Disease Activity and Disability Progression of Relapsing-Remitting Multiple Sclerosis in patients with Natalizumab: A Single-Centre Retrospective Observational Study Majoul, Mohamed Slim

92 C p.
artikel
123 162. Long-term Effectiveness of Cladribine Tablets over 4 years in Relapsing Multiple Sclerosis: Results from the MAGNIFY-MS Extension Study De Stefano, Nicola

92 C p.
artikel
124 161. Long-term Effects of Cladribine Tablets Treatment on Cognition, Relapses, MRI, and Safety Outcomes in Patients with Relapsing Multiple Sclerosis: 4‑year Results from the CLARIFY-MS Extension study Selmaj, Krzysztof

92 C p.
artikel
125 Long-term follow-up MR imaging in children with transverse myelitis El Naggar, Ines

92 C p.
artikel
126 52. Long-term Real-world Safety and Efficacy of Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience Yamout, Bassem

92 C p.
artikel
127 45. Lost in Transition: Understanding Fingolimod Withdrawal and its Impact on Multiple Sclerosis Patients Al-Draye, Hamad

92 C p.
artikel
128 160. Low Rate of Progression Independent of Relapse Activity (PIRA) in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets De Stefano, Nicola

92 C p.
artikel
129 166. Management of Multiple Sclerosis from Patients', Physicians', and Patient Group's Perspectives in Saudi Arabia Aljarallah, Salman

92 C p.
artikel
130 115. Marbled Thalamus Appearance: A Radiological Feature Suggestive of Neuromyelitis Optica Spectrum Disorder (NMOSD) Nouri, Dorsaf

92 C p.
artikel
131 94. MRI Findings in Neuro-Behçet's Disease: A 7-Year Retrospective Study Asma, Ben Khalifa

92 C p.
artikel
132 Multiple Sclerosis and biological definitions in neurodegenerative diseases Camara-Lemarroy, Carlos R.

92 C p.
artikel
133 68. Multiple Sclerosis and Epilepsy: Much More Than a Coincidence Daoud, Sawsan

92 C p.
artikel
134 Multiple sclerosis-associated uveitis in Persian population, a multicenter study Anvari, Pasha

92 C p.
artikel
135 Multiple sclerosis disease-modifying therapy use in the department of veteran affairs and Medicare: A comparative analysis Hartung, Daniel M.

92 C p.
artikel
136 15. Multiple Sclerosis Mimicrs on Imaging: A Pictorial Review Al-Draye, Hamad

92 C p.
artikel
137 Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology–a review Oreja-Guevara, Celia

92 C p.
artikel
138 21. Multiple Sclerosis Prevalence among Tehran Residence: Updates from MS registry of Iran Eskandarieh, Sharareh

92 C p.
artikel
139 143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry Ezabadi, Sajjad Ghane

92 C p.
artikel
140 Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis Søndergaard, Helle Bach

92 C p.
artikel
141 41. Neuropathic Pain in Multiple Sclerosis Farah, Kchaou

92 C p.
artikel
142 42. Neuropathic Pain in Multiple Sclerosis: Serum Biomarkers and Correlation with MRI Lesion Localization Sarhan, Noha T

92 C p.
artikel
143 New insights into the use of high dose corticosteroids and plasmapheresis in persons with MOGAD and NMOSD Kosior, N

92 C p.
artikel
144 Non-invasive brain stimulation enhances the effect of physiotherapy for balance and mobility impairment in people with Multiple Sclerosis. Ghosh, Soumya

92 C p.
artikel
145 Observational study of gadolinium-enhancing lesions in MRI in patients with multiple sclerosis from the Spanish Mediterranean coast: Seasonal variability and relationship with climatic factors Romero Del Rincón, Celia

92 C p.
artikel
146 168. Ocrelizumab in Real Clinical Practice of one Municipal Clinical Hospital in Moscow: Experience of Prescription, Safety and Efficacy Problems Kukushkina, Anna

92 C p.
artikel
147 179. Ocrelizumab Subcutaneous Injection in Patients with Multiple Sclerosis: Further Characterisation of the Benefit–risk Profile from the OCARINA Clinical Development Programme Newsome, S.D.

92 C p.
artikel
148 3. Outcome of Multiple Sclerosis with and without Optic Neuritis Alshyaokh, Fatima

92 C p.
artikel
149 119. Paraneoplastic Devic's Disease Farhat, Nouha

92 C p.
artikel
150 92. Paroxysmal Dystonia Presenting as the First Sign of Multiple Sclerosis: A case report Rekia, Adjmi Roumaissa

92 C p.
artikel
151 59. Patient Perspectives and Nursing Satisfaction in the Evaluation of High Efficacy Treatment in Multiple Sclerosis: A Cross-sectional Study Pastore, Francesco

92 C p.
artikel
152 Patterns of cognitive decline across different multiple sclerosis clinical courses Negreiros, André Augusto Lemos Vidal de

92 C p.
artikel
153 95. Patterns of Corpus Callosum Lesions in Demyelinating Diseases of the Central Nervous System Hafsa, Meriem Ben

92 C p.
artikel
154 99. Pediatric Multiple Sclerosis Altered Diagnosis in a Tertiary Referral Center: A Retrospective Study Jahani, Shima

92 C p.
artikel
155 Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome Xie, QinFang

92 C p.
artikel
156 170. Physical Activity and Fatigue in Multiple Sclerosis Patients Sakka, Salma

92 C p.
artikel
157 129. Physical Activity and Inflammatory Markers in Multiple Sclerosis Patients: A Study of a Tunisian cohort Sakka, Salma

92 C p.
artikel
158 Physical activity improves cardiovascular fitness and reduces cardiovascular risk factors in adults with multiple sclerosis: A systematic review and meta-analysis Lin, Chun-Chen

92 C p.
artikel
159 140. Physicians’ Perspectives on Barriers to Multiple Sclerosis Care in United Arab Emirates: A Survey Study Mir, Ruqqia

92 C p.
artikel
160 Plasma levels of polyunsaturated fatty acids and multiple sclerosis susceptibility in a US case-control study Dunlop, Eleanor

92 C p.
artikel
161 146. Post-Approval Safety of Cladribine Tablets in the Treatment of Patients With Multiple Sclerosis: 2024 Update Leist, Thomas

92 C p.
artikel
162 Preceding hepatitis B virus infection is highly prevalent in patients with neuromyelitis optica spectrum disorder in Taiwan Ou Yang, Wen-Yu

92 C p.
artikel
163 Predicting faller status in persons with multiple sclerosis using the Multiple Sclerosis Walking Scale-12 Abate, Caterina

92 C p.
artikel
164 Preferences and attitudes regarding early intervention in multiple sclerosis: A systematic literature review Martin, Sylvia

92 C p.
artikel
165 176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date Dobson, R

92 C p.
artikel
166 49. Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide Rashed, Mohamed Abdalla

92 C p.
artikel
167 7. Pregnancy Outcomes in Patients with Multiple Sclerosis with or without Exposure to Disease-Modifying Treatment: A Retrospective Cohort Study on Iranian Population Paybast, Sepideh

92 C p.
artikel
168 65. Prevalence and Factors Contributing for Developing Cognitive Impairment Among 200 Multiple Sclerosis Patients: A Hospital Based Study Khedr, Eman M

92 C p.
artikel
169 172. Prevalence and Impact of Complementary and Alternative Medicine Use Among Multiple Sclerosis Patients in Saudi Arabia Aljarallah, Salman

92 C p.
artikel
170 128. Prevalence and Impact of Digestive Disorders in Multiple Sclerosis in a Hospital Cohort Imen, Ben Kraiem

92 C p.
artikel
171 72. Prevalence, Characteristics and Risk Factors of Seizures Among Patients with Multiple Sclerosis Aljarallah, Salman

92 C p.
artikel
172 63. Prevalence of Anxiety and its Associated Factors in Multiple Sclerosis: Insights from an Algerian Cohort Khermache, Ali

92 C p.
artikel
173 19. Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt El-Tallawy, Hamdy N.

92 C p.
artikel
174 76. Prevalence of Sleep Disorders and Their Impact on Quality of Life in a Large Cohort of Patients with MS: A Hospital based study Khedr, Eman M

92 C p.
artikel
175 75. Prevelance of Primary Headache in Iraqi Patients with Relapsing Remitting Multiple Sclerosis Algburi, Saif Mohammed

92 C p.
artikel
176 22. Prodromal or Early Multiple Sclerosis: An Algerian Case-Control Study of Emerging Evidence and Utility Kediha, Mohamed Islam

92 C p.
artikel
177 114. Prognosis Predictors in Neuromyelitis Optica Spectrum Disorder: A Tunisian Cohort Study Othman, Oumayma Ben

92 C p.
artikel
178 Progressive multifocal leukoencephalopathy associated with sphingosine-1-phosphate receptor modulators: A large case series Croteau, David

92 C p.
artikel
179 174. Prolonged B-Cell Depletion Post-Rituximab in a Patient with Neuromyelitis Optica Spectrum Disorder (NMO-SD): A Case Report with Literature Review Samad, Omar Abdel

92 C p.
artikel
180 164. Prospective Multi Centered Study on the Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis Patients Al-Mahdawi, Akram M.

92 C p.
artikel
181 101. Pseudotumor Demyelinating Lesions in Inflammatory Diseases of the Central Nervous System: An Algerian Series Kediha, Mohamed Islam

92 C p.
artikel
182 64. Psychological and Sexual Health in MS Patients: Findings from an Algerian Cohort Khermache, Ali

92 C p.
artikel
183 Psychometric properties of patient-reported outcome measures, measuring fatigue in patients with multiple sclerosis, a systematic review Ruzzi, Miguel Angel Jorquera

92 C p.
artikel
184 147. Quality of Life and Treatment Satisfaction in Relapsing-Remitting Multiple Sclerosis: A Comparative Analysis of Dimethyl Fumarate (DMF) in Switchers and Treatment-Naïve Patients Abolfazli, Roya

92 C p.
artikel
185 26. Quantitative Evaluation of Lesion Load in Multiple Sclerosis using Multimodal MR Wen, Puti

92 C p.
artikel
186 31. Quantitative susceptibility mapping (QSM)-based regional iron concentration: Does it correlate with brain volume loss? An analysis of 250 regions of interest (ROIs) Hamdy, Eman

92 C p.
artikel
187 123. Rare Association Between Neuromyelitis Optica Spectrum Disorder, Anti-synthetase Syndrome and Systemic Lupus Erythematosus in an Adult Female Kediha, Mohamed Islam

92 C p.
artikel
188 163. Real-Life Impact of Fingolimod on Multiple Sclerosis Treatment Aljahdali, Naila

92 C p.
artikel
189 70. Real-World Experience of Cladribine Tablets in the Treatment of Multiple Sclerosis: An Omani Cohort from Khoula Hospital Redha, Iman

92 C p.
artikel
190 89. Real-world Safety and Efficacy of Teriflunomide (Tebazio®) in Iranian Females with Relapsing-Remitting Multiple Sclerosis Sabeti, Fatemeh

92 C p.
artikel
191 28. Relationship between Neurofilament Light Chain levels and Disability Progression in Patients with Multiple Sclerosis Mrabet, Saloua

92 C p.
artikel
192 157. Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Subjects Lefèvre, Gilbert

92 C p.
artikel
193 103. Risk Factors Affecting the Age at Onset in Adult Patients with Multiple Sclerosis Lapevandani, Mahsa Mohammadi

92 C p.
artikel
194 53. Risk of Malignancy and the Use of Disease-Modifying Therapy in Multiple Sclerosis: Exploring the Role of DMT in a Multi-Center Study Bayounis, Mohammed

92 C p.
artikel
195 151. Safety and Efficacy of Frexalimab in the Treatment of Relapsing Multiple Sclerosis: 18-month Results from the Phase 2 Open-Label Extension Giovannoni, Gavin

92 C p.
artikel
196 156. Safety of Remibrutinib across Immune-mediated Diseases Supports Development in Multiple Sclerosis Kieseier, Bernd C.

92 C p.
artikel
197 17. Season of Birth and Multiple Sclerosis in the Middle East and North Africa Ali, Mohammad Aboulwafa

92 C p.
artikel
198 Segmental abnormalities of white matter microstructure in multiple sclerosis and neuromyelitis optica spectrum disorder identified by automated fiber quantification Xie, Yan

92 C p.
artikel
199 118. Seroconversion in Neuromyelitis Optica Spectrum Disorder Hadjkacem, Donia

92 C p.
artikel
200 108. Serum Biomarkers and Their Association with Clinical, Cognitive, and Quality of Life Parameters in Disease-Modifying Therapy-Naive Multiple Sclerosis Patients Khedr, Eman M

92 C p.
artikel
201 100. Serum Derived microRNA as a Diagnostic Biomarker for Multiple Sclerosis Subtypes in Saudi Population: A Pilot Study Zailaie, Samar Abdullah

92 C p.
artikel
202 27. Serum Neurofilament Light Chain as a Diagnostic Marker in Drug-Naive Multiple Sclerosis Patients: A Cross-Sectional Hospital Based Study Khedr, Eman Mohammed

92 C p.
artikel
203 83. Serum Neurofilament Light Chain Levels and Glial Fibrillary Acidic Protein are Prognostic Biomarkers of Disability Worsening in Multiple Sclerosis Patients Hassoun, Hayder K.

92 C p.
artikel
204 Sex differences in use of potentially teratogenic disease modifying treatments for multiple sclerosis and degree of hormonal contraception overlap in women between 2007–2021: An Australian population-based study Fragkoudi, A.

92 C p.
artikel
205 77. Sleep Disturbances and Associated Factors in Multiple Sclerosis Hamed, Nouha Ben

92 C p.
artikel
206 78. Sleep Quality Among People with Multiple Sclerosis: Application of the International Classification of Functioning, Disability, and Health Model Al-Sharman, Alham

92 C p.
artikel
207 12. Sleep Quality Is Not a Predictor of Information Process Speed in Multiple Sclerosis: A Systematic Review and Meta-analysis Naseri, Amirreza

92 C p.
artikel
208 Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosis Giovannoni, Gavin

92 C p.
artikel
209 80. Status of Cerebrospinal Fluid Oligoclonal Bands among Patients with Multiple Sclerosis at King Abdulaziz Medical City Abulaban, Ahmad Abdulaziz

92 C p.
artikel
210 Step to the beat: Auditory-motor coupling during walking to higher and lower tempi with music and metronomes in progressive multiple sclerosis: An observational study Vanbilsen, Nele

92 C p.
artikel
211 71. Stroke Incidence in Multiple Sclerosis: A Systematic Review and Meta-Analysis Ketata, Imen

92 C p.
artikel
212 79. Sustained Treatment Persistence and High Adherence to Cladribine Tablets in Multiple Sclerosis: Results from Patient Support Program in Gulf Countries Alroughani, Raed

92 C p.
artikel
213 30. Thalamic Volume Differentiates Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorder Aljarallah, Salman

92 C p.
artikel
214 90. The Clinical and Neurochemical Effect of Transcranial Magnetic Stimulation on the Unusual Symptoms of Multiple Sclerosis Tohamy, Amal

92 C p.
artikel
215 10. The Comparative Ability of Five Mobility and Balance Outcome Measures in Predicting the Risk of Falls in People with Multiple Sclerosis Khalil, Hanan

92 C p.
artikel
216 51. The Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World based Study Zeineddine, Maya

92 C p.
artikel
217 The correlation between rituximab dose reduction and acute relapses of neuromyelitis optica spectrum disorder, lessons from COVID-19 epidemic Ashtari, Fereshteh

92 C p.
artikel
218 113. The Correlation Between Serum Neurofilaments Levels and Brain Iron Load and 2D Brain Volume Parameters: A Pilot Study Hamdy, Eman

92 C p.
artikel
219 20. The Design of National Neuromyelitis Optica Spectrum Disorders Registry System of Iran Eskandarieh, Sharareh

92 C p.
artikel
220 158. The Impact of Natalizumab on Neuropsychological Function in Multiple Sclerosis Patients Zouari, Rania

92 C p.
artikel
221 104. The Influence of Parental Autoimmune Diseases on the Development of Multiple Sclerosis: Findings from a Case-Control Study Khodadadi, Sanaz

92 C p.
artikel
222 The multiple sclerosis gut microbiome and disease activity: A systematic review Jette, Sophia

92 C p.
artikel
223 39. The Neuroimmunological Manifestations of Covid-19 the Most Extensive Review of Published Case Reports Al-Draye, Hamad

92 C p.
artikel
224 120. The Pathological Findings of the First Cervical Spine MRI of The Neuromyelitis Optica Spectrum Disorders Patients Mehdipour, Roshanak

92 C p.
artikel
225 The perspectives of neurologists on positron emission tomography utility in multiple sclerosis: A qualitative study Ezzat, Daniel

92 C p.
artikel
226 4. The Prevalence of Comorbidities Associated with Multiple Sclerosis in Saudi Arabia Alnajashi, Hind

92 C p.
artikel
227 124. The Prevalence of Iron Overload in Patients with Multiple Sclerosis in National Guard Health Affair Hospital, Riyadh Center from 2015-2021 Alanazi, Asma

92 C p.
artikel
228 181. The Real-world Efficacy and Safety of Off-label Rituximab in a Large Cohort of Middle Eastern Multiple Sclerosis Patients Ismail, Ghida

92 C p.
artikel
229 The real-world impact of biologics for NMOSD: A retrospective single-center study compared with natural course and conventional treatments in Japanese Yamazaki, Naoya

92 C p.
artikel
230 84. The Relationship between Fatigue and MRI Volumetric Markers among Patients with Early Relapsing-remitting Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Ashtari, Fereshteh

92 C p.
artikel
231 The role of disease modifying therapies in late-onset multiple sclerosis: A Portuguese multicentric characterization study Faustino, Patrícia

92 C p.
artikel
232 2. Triaging Multiple Sclerosis at the Emergency Department: A Proposed Algorithmic Approach Al-Draye, Hamad

92 C p.
artikel
233 121. Tumefactive Myelin Oligodendrocyte-Associated Disease Presenting as Acute Flaccid Myelitis: A Case Report Haroun, Lynda

92 C p.
artikel
234 145. Two-year Results of Patient-Reported Outcomes in Patients with Multiple Sclerosis Treated with Ocrelizumab in a Large Real-World Setting: MuSicalE Interim Analysis Trojano, Maria

92 C p.
artikel
235 36. Uncommon Initial Presentation of Neuromyelitis Optica Spectrum Disorder: Short-lasting Unilateral Neuralgiform Headache with Autonomic Symptoms (SUNA)- A Case report Adjmi, Roumaissa Rekia

92 C p.
artikel
236 37. Underemployment, Work Hour Reduction, and Income Loss: A Global, Multi-centered, Cohort Study of Neuromyelitis Optica Hjerthen, Isabella Gomez

92 C p.
artikel
237 87. Understanding the Potential Therapeutic and Rehabilitative Role of Transcranial Magnetic Stimulation in Multiple Sclerosis Bashir, Shahid

92 C p.
artikel
238 33. Unmasking Stroke Presentation for Elderly Onset Demyelination Galeel, Aya Abdel

92 C p.
artikel
239 165. Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab Craner, Matthew

92 C p.
artikel
240 Untackling the economics of multiple sclerosis: A systematic review of economic evaluations of disease-modifying therapies indicated for multiple sclerosis Petrou, Dr Panagiotis

92 C p.
artikel
241 111. Usefulness of Phase Sensitive Inversion Recovery MRI Sequence in the Detection of Cortical Lesions in Multiple Sclerosis Shakir, Rezq Ahmed

92 C p.
artikel
242 Utility of icobrain for brain volumetry in multiple sclerosis clinical practice Nguyen, Ai-Lan

92 C p.
artikel
243 96. Value of Central Vein Sign in Differentiating Between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders Galeel, Aya Abdel

92 C p.
artikel
244 23. Vanishing Clues: A Systematic Review of Oligoclonal Band Disappearance in Multiple Sclerosis Patients after Treatment Al-Draye, Hamad

92 C p.
artikel
245 Vitamin D and cardiovascular outcomes in multiple sclerosis France-Ratcliffe, Madeleine

92 C p.
artikel
246 102. When Multiple Sclerosis and Neuro Behcet Disease Meet: What Management to Adopt? Kediha, Mohamed Islam

92 C p.
artikel
                             246 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland